MedTrace Logo

Post Acute Pancreatitis Pancreatic Exocrine Insufficiency

NCT03063398 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 196

Last updated 2024-07-16

No results posted yet for this study

Summary

This study is a proposed a comprehensive prospective assessment of exocrine pancreatic insufficiency (EPI), nutritional status, and quality of life (QOL) during the early re-feeding phase, at 3 months, and 12 months following an AP attack.

Conditions

Interventions

DIAGNOSTIC_TEST

No intervention, this is an observational study

Assessment for exocrine pancreatic insufficiency

Sponsors & Collaborators

  • AbbVie

    collaborator INDUSTRY

  • Ohio State University

    lead OTHER

Principal Investigators

  • Georgios I Papachristou, MD · Ohio State University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-06-21
Primary Completion
2023-02-01
Completion
2024-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03063398 on ClinicalTrials.gov